Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to R01:11

Introduction to R

5.0K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
5.0K
Introduction to force01:25

Introduction to force

1.2K
Consider water flowing from a nozzle to a turbine vane. As the water hits the turbine vane, it exerts a force that causes it to move along the flow of direction. Force is an impact that changes an object's motion, shape, or orientation. Forces can be caused by physical contact, such as a push or pull, or through non-contact interactions, such as magnetic or gravitational forces. Force is a vector quantity with both magnitude and direction, and is measured in newtons (N) in the SI unit...
1.2K
Introduction to Urinary System01:13

Introduction to Urinary System

9.2K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
9.2K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

2.2K
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
2.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

908
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
908
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

2.5K
The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.

Muscle & nerve·2026
Same author

Study 19 (MCI186-19) Post Hoc Analyses.

Muscle & nerve·2026
Same author

Safety of Intravenous Edaravone in Clinical Practice.

Muscle & nerve·2026
Same author

Generalizability of Edaravone Efficacy.

Muscle & nerve·2026
Same author

Current and Ongoing Clinical Studies.

Muscle & nerve·2026
Same author

Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis.

Muscle & nerve·2025
Same journal

IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

Muscle & nerve·2026
Same journal

Mindfulness for Myasthenia Gravis.

Muscle & nerve·2026
Same journal

Cure in Myasthenia Gravis: An Unmet Need.

Muscle & nerve·2026
Same journal

Treatment Preferences of Patients With Myasthenia Gravis: A Qualitative Study.

Muscle & nerve·2026
Same journal

At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial.

Muscle & nerve·2026
Same journal

The Use of the Four Square Step Test and the 10-m Walk/Run Test to Determine Fall Risk in Children With Duchenne Muscular Dystrophy.

Muscle & nerve·2026
See all related articles

Related Experiment Video

Updated: Feb 8, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.6K

Introduction to the Supplement.

Kelly G Gwathmey1, Stephen Apple2

  • 1Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.

Muscle & Nerve
|February 7, 2026
PubMed
Summary
This summary is machine-generated.

Edaravone, a treatment for Amyotrophic Lateral Sclerosis (ALS), offers a new oral suspension formulation. This expands treatment options for ALS patients, building on the established benefits of its intravenous form.

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Research

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a progressive neuromuscular disease with diverse patient presentations.
Keywords:
Study 19amyotrophic lateral sclerosisedaravoneefficacysafety

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.9K
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
07:33

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs

Published on: July 6, 2015

12.0K

Related Experiment Videos

Last Updated: Feb 8, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

17.6K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.9K
Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
07:33

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs

Published on: July 6, 2015

12.0K
  • Current FDA-approved treatments for ALS include riluzole, edaravone (IV and oral), and tofersen.
  • Edaravone's efficacy was initially shown in Japanese patients (Study 19), leading to IV formulation approval.